CD44 is a potentially rewarding target in cancer therapy, although its mechanisms of ligand binding and internalization are still poorly understood. In this study, we have established quantitative relationships between CD44 expression in differently polarized macrophages (M0, M1, and M2-polarized THP-1 human macrophages) and the uptake of hyaluronic acid (HA)-based materials, which are potentially usable for CD44 targeting. We have validated a robust method for macrophage polarization, which sequentially uses differentiating and polarizing factors, and allows to show that CD44 expression depends on polarization (M1 > M0 ≥ M2). It is noteworthy that THP-1 M2 expressed CD44v6, suggesting their suitability as a model of tumor-associated macrophages. In the uptake of HA, both as a soluble polymer and in the form of (siRNA-loaded) nanoparticles, CD44 expression correlated positively with binding, but negatively with internalization. Counterintuitively, it appears that a higher presence of CD44 (in M1) allows a more efficient capture of HA materials, but a lower expression (in M2) is conducive to better internalization. Although possibly cell-specific, this unexpected relationship indicates that the common paradigm "higher CD44 expression = better targetability" is too simplistic; mechanistic details of both receptor presentation and association still need to be elucidated for a predictable targeting behavior.
CD44 is a potentially rewarding target in cancer therapy, although its mechanisms of ligand binding and internalization are still poorly understood. In this study, we have established quantitative relationships between CD44 expression in differently polarized macrophages (M0, M1, and M2-polarized THP-1 human macrophages) and the uptake of hyaluronic acid (HA)-based materials, which are potentially usable for CD44 targeting. We have validated a robust method for macrophage polarization, which sequentially uses differentiating and polarizing factors, and allows to show that CD44 expression depends on polarization (M1 > M0 ≥ M2). It is noteworthy that THP-1 M2 expressed CD44v6, suggesting their suitability as a model of tumor-associated macrophages. In the uptake of HA, both as a soluble polymer and in the form of (siRNA-loaded) nanoparticles, CD44 expression correlated positively with binding, but negatively with internalization. Counterintuitively, it appears that a higher presence of CD44 (in M1) allows a more efficient capture of HA materials, but a lower expression (in M2) is conducive to better internalization. Although possibly cell-specific, this unexpected relationship indicates that the common paradigm "higher CD44 expression = better targetability" is too simplistic; mechanistic details of both receptor presentation and association still need to be elucidated for a predictable targeting behavior.
effect, [7] or both. [8] The downsides of this approach are the competition with the host's own HA, and the moderate (from a few to hundreds of micromolars [9] ) affinity of CD44 for HA, which is also affected by a number of complicating factors, e.g., posttranslational modifications [9] and in particular N-glycosylation, [10] which affect the HA-binding LINK module as well as flanking sequences, [11] mechanical action, [12] the presence of CD44 in a soluble form, [13] and also the variable degree of clustering of this receptor. B) Monoclonal antibodies. Their CD44 ligation contributes to both targeting and therapeutic effects [14] putatively ascribed to the disruption to CD44/HA interactions; for example, this is the proposed mechanism of action for the humanized recombinant RG7356, [15] which is likely the most widely used member of this family and has completed Phase I clinical trials. [16] A number of CD44 monoclonal antibodies are commercially available, some being specific to one variant isoform (e.g., the tumor-associated CD44v6 for VFF-7, [17] or CD44v10 for MEM-85, [18] ) some having the non-variable region as the immunogen (e.g., RG7356). In a recent screening it has been shown that intermediate but not high affinity often correlates to high tumor uptake. [19] The drawbacks of antibodies are their potential immunogenicity, the possibly excessive specificity (which requires an appropriate patient stratification [20] ), and the CD44 variability, as discussed for HA.
HA-based systems can be more easily combined with a variety of active principles and have a lower cost, whereas antibodies have intrinsic therapeutic activity and higher targeting efficiency. For both classes, we still do not fully understand how CD44 expression affects binding (strictu sensu targeting), and how this relates to internalization; in this study we tackle these issues, using our experience with chitosan/HA (CS/HA) nanoparticles [21] and soluble HA. [22] Here we use macrophages as a cellular model, because (a) macrophages have a high CD44 expression and play a major role in HA uptake and degradation; [23] (b) they should offer considerably less variability in CD44 structure and behavior than cancer cells; therefore, they are an easier starting point; (c) they are the prototypical off-target destination for any carrier-based therapy; therefore, understanding their interactions with HA is important for the design of carriers with improved pharmacokinetics; (d) they can be therapeutic targets themselves, if the tumor-associated macrophages (M2-like) are reprogrammed into a potentially tumoricidal (M1-like) phenotype. [24] In terms of the macrophage model, we have excluded primary human macrophages (difficult and invasive isolation, unable to proliferate in culture, significant donor-to-donor variations); murine cell lines such as RAW 264.7 have been extensively studied for CD44 functionality [25] and nanoparticle uptake, [21] and in a handful of cases their polarization has also been investigated, [26] but the human translatability of their classical or alternative activation is questionable. We have employed the human THP-1 cell line because: (a) these premonocytes show commitment toward macrophage lineages, [27, 28] (b) the differentiated cells resemble native monocyte-derived macrophages in terms of morphology, antigen expression, and secretory products, [27, 28] (c) their polarization has been studied rather extensively, and in particular the alternatively activated THP-1 cells are often regarded as a reasonable model of tumorassociated macrophages. [29] However, to date there is no consensus about the conditions for THP-1 in vitro polarization; for example, differentiating (phorbol 12-myristate-13-acetate, PMA) and polarizing (lipopolysaccharides, LPS, and IFN-γ for M1; IL-4 and IL-13 for M2) have been used in co-incubation [30] or in sequential treatments, [29] nominally obtaining the same kind of activation, but without a quantitative comparison of the relevant phenotype markers. For this reason, we have first comparatively evaluated a set of protocols with the aim to maximize the morphological and biochemical differences between differently polarized THP-1 macrophages, and studied how macrophage polarization may affect the expression of CD44. Then, we have set out to establish a qualitative link between CD44 presence and the different phases of uptake (binding and internalization) of both soluble HA and HA-based nanoparticles.
Results and Discussion

The Cellular Model
We have used two different differentiation/polarization protocols ( Figure 1A ): 1) A 24 h combined treatment (used, e.g., by Tjiu et al. for M2 THP-1 [30] ) referred to as [6/18]; premonocytes (Mo) were first incubated with PMA (6 h), then with PMA + polarizing factors (18 h). 2) A 48 h sequential treatment (similar to that used by Genin et al. to obtain M1 and M2 THP-1 [29] or by Martinez et al. on primary cells [31] ) referred to as [24/24], where premonocytes were first incubated with PMA alone (24 h), then with polarizing factors alone (24 h).
In order for all cells to experience the same overall treatment duration (48 h), in some cases we have employed a final resting phase: [6/18] macrophages were cultured for additional 24 h in full medium, and so were also M0 macrophages (24 h PMA differentiation, 24 h resting: protocol [24]). Conversely, in the sequential [24/24] treatment the cells were not subjected to any resting time. Since the presence or absence of a resting time can be important (M1-like polarization arises in THP-1 after a 5 d resting following a 24 h treatment with 200 × 10 −9 m ≈ 120 ng mL −1 PMA), [28] we have also subjected M0 to a 48 h recovery in a protocol is referred to as [24]*: any difference with [24] treatment will reflect the effect of a prolonged resting.
Cell Viability: None of the treatments leading to M0 and M2 phenotypes affected cell viability, whereas a moderate reduction was observed for M1: about 20% of dead cells were seen in live/dead assays, whereas MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay recorded a ≈30% decrease in average mitochondrial activity (see Figure S1 in the Supporting Information).
Cell Morphology (Figure 1B,C): M0 and M2 macrophages exhibited almost identically round bodies (high solidity and thickness, low surface area; Figure 1B , left) and similar morphology ( Figure 1B , right) on plastic, and also similar cellular size and granularity in suspension (Figure 1C , right;, see the caption for parameter definitions), always without noticeable differences between the two polarization protocols. M1 were flatter and more spread, indicating a higher adhesion to the substrate, and were larger and more granular in suspension, with the M1 versus M0/M2 differences being more evident using the [24/24] protocol. Finally, the resting time ( [24] vs [24]* for M0) had no effect.
Surface Markers (Figure 2 ): In short, the three markers employed were all present in larger amounts under the [24/24] protocol.
A) CD14 (LPS co-receptor, Figure 2A ) is a differentiation marker for the myelomonocytic stem cell line; [32] more specifically, its upregulation marks the THP-1 premonocyteto-macrophage differentiation, [28, 33, 34] although at low PMA doses this may not be observed, e.g., in Aldo et al. same cell density as here, but ten times less PMA. [35] [36] than in the M2 state. [37] B) CD11c (leukocyte integrin, Figure 2B ) is a general marker of mononuclear phagocytes (particularly abundant in dendritic cells; [38] ) it is induced in macrophage maturation, and it is typically upregulated with PMA. [39] Our results confirmed both its presence in Mo and its upregulation as the result of maturation processes. [40] which suggests the identification of the [24/24] M2 cells as M2a.
(3 of 11) 1601012 C) CD206 (macrophage mannose receptor, Figure 2C ) is considered to be an alternative activation marker, [41] Cytokine Profiling: Three cytokines (TNF-α, IL-1β, and TGF-β1, Figure 2D ) were analyzed for a final assessment of the polarization into pro-inflammatory and anti-inflammatory subtypes; a fourth marker, IL-10, was under the detection limit for the three macrophagic polarizations (data not shown), which may be a peculiarity of THP-1 [42] (in addition to what is seen for CD206). In short, the two polarization protocols were largely similar. Not surprisingly, the highest levels of pro-inflammatory cytokines (TNF-α and IL-1β) were detected for the M1 phenotype, while being lower for M0 and lowest for M2 macrophages. M2 macrophages showed the highest levels of (latent) TGF-β1.
On the grounds of the increased upregulation of all differentiation markers, the [24/24] protocol was chosen for all further polarization experiments, using the analogous [24] protocol for M0 polarization.
Expression of CD44 and of Its Isoforms
CD44 was already present in Mo, but its expression increased upon their differentiation (see Figure S2 in the Supporting Information; compare to literature reports, [43] also with regards to HA affinity. [44] ) CD44 exhibited a punctuated fluorescence preferentially localized at or close to the cell surface, without any noticeable difference for the three macrophage polarizations (red in Figure 3A) ; qualitatively, CD44 appeared to be present in larger amounts in M1, and this was then quantitatively confirmed via various techniques: (1) Western blotting ( Figure 3B ) indicated CD44 expression in the order M1 > M0 > M2 ≥ Mo. In comparison to Mo premonocytes, M0 showed a 3.5-fold increase, M1 a 5.5-fold increase, and M2 a 1.25-fold increase. . THP-1 macrophage markers; please note that thermosensitive substrates were employed in order to avoid degradation and/or removal of surface proteins. A) The expression of CD14, B) CD11c, and C) CD206 on THP-1 was evaluated via flow cytometry using primary antibodies. The Median Fluorescence Intensity (MFI) for PMA-treated (M0), LPS+IFN-γ-treated (M1), and IL-4+IL-13-treated (M2) cells is expressed in relation to that of their parent, untreated monocytes (blue horizontal bar). D) The levels of TNF-α, IL-1β, and TGF-β1 were measured via ELISA. Notice that the differences in terms of both marker expression and release of cytokines were not affected by differences in cell viability for the two experimental protocols (see Section SI1 and Figure S1 in the Supporting Information). Data are presented as average ± SD of n = 3 experiments (flow cytometry) and of n = 4 experiments (ELISA). The statistical analysis refers to the comparison of receptor expression in different polarizations: *** P < 0.001, ** P < 0.01, *P < 0.05 (Two-way ANOVA).
(5 of 11) 1601012
(2) Direct staining flow cytometry ( Figure 3C ) and (3) indirect staining flow cytometry ( Figure 3D ) provided a similar picture, with the only difference that CD44 expression in M0 and M2 is statistically indistinguishable, confirming literature reports that it remains largely unaffected by alternative activation. [45] [24] M1, [24/24] and M2 [24/24] cells. β-actin was used as loading control. Average ± SD (n = 3) is reported in the left panel. C) Expression of CD44 obtained via direct staining flow cytometry (APC-labeled anti-CD44 mAb). Incidentally, these data are analogous to the expression recorded using [6/18] and [24]* protocols (see Figure S2 in the Supporting Information). Average ± SD (n = 3). D) Expression of total CD44 (CD44pan; same stain as for Western blotting) and CD44 variants (CD44v3, CD44v4, and CD44v6) by flow cytometry after indirect staining with AlexaFluor647 (AF647). The cells were detached using an enzyme-free protocol, which provided quantitative cell recovery while maintaining full viability (see Section SI3 and Figure S3 in the Supporting Information). Histogram of n-fold change in MFI over isotype control (left), and percentage of positive cells for the various cell populations (right) are expressed as average ± SD (n = 3). For more complete data, see Figure S4 in the Supporting Information. For the statistical comparison between the three highlighted peaks and the isoform presence in other polarizations: *** P < 0.001, In terms of CD44 splice variants, the absence of intense secondary bands in the Western blots ( Figure 3B ) already suggests standard CD44 (≈85-90 kDa) to be the predominant isoform. We have confirmed this by assessing the presence of some CD44 variants (CD44v3, v4, and v6, among the most relevant in cancer [46] ) in relation to the total CD44 ( Figure 3D ). These isoforms appeared to be marginally present in Mo, and substantially absent in M1 and M2, with one notable exception: at least 60% of the M2 population was positive for CD44v6, showing peripheral/membrane localization virtually identical to that of the standard variant ( Figure 3E ). Although never clearly associated to M2, the scarce evidence about the expression of CD44v6 in macrophages aligns with our finding: this variant (in a soluble form) was found to be produced in monocytes undergoing macrophagic differentiation, [47] while it has been shown that infiltrating (most likely M1) leukocytes in skin are completely devoid of CD44v6. [48] Besides the possible use of CD44v6 as a marker of THP-1-M2 polarization, it is tempting to think about its utility for M2 macrophage targeting.
Complex Relationship between Uptake of HA Materials and CD44 Expression
We have prepared rhodamine-labeled HA (HA-Rho; M w = 180 kDa, 0.7% mol functionalization), and used it as such as a soluble ligand, or in the form of CS/HA nanoparticles. The latter were produced via direct polyelectrolyte complexation employing CS with two different molecular weights, and were loaded with a DY547-labeled siRNA in order to provide a generic model for HA-decorated nanocarriers. Please note that they differ from soluble HA both in size and in surface density of CD44-binding groups (HA is more condensed when bound to CS).
We have followed the uptake kinetics of both soluble HA and of CS/HA nanoparticles by monitoring their fluorescence in cell lysates and via flow cytometry after trypsinization. The fluorescence of cell lysates accounts for both surface bound and internalized material; on the contrary, due to the trypsinmediated degradation of CD44 [49] and the ensuing removal of membrane-bound HA, [50] we assume that flow cytometry predominantly refers to internalized material. This assumption is confirmed by the negligible effect of an extracellular fluorescence quencher (trypan blue, data not shown) in flow cytometry experiments.
For all the three macrophage polarizations, the fluorescence of cell lysates (black symbols in all panels of Figure 4A ) reached a plateau already at 2 h for soluble HA and at 4 h for nanoparticles, with virtually all cells being positive for internalized material.
This indicates a rapid binding and saturation of the HA receptor(s), which we predominantly identify as CD44, due to the significant inhibition obtained with the Hermes-1 antibody, specifically for M1 and M2 (2 h, HA-Rho fluorescence in cell lysates; Figure 4D ).
Flow cytometry showed the internalization kinetics to proceed much more slowly (purple symbols in all panels of Figure 4A ). Since the 2 h internalization appeared to be almost negligible, we have considered the 2 h cell lysate data as an indication of the capacity of the three macrophage polarizations to bind free HA or CS/HA nanoparticles. On the other hand, we have used the 16 h flow cytometry median fluorescence intensity (MFI) as a measure of their internalization efficiency. We have then cross-correlated for each macrophage phenotype these binding and internalization data with the expression of CD44, as quantified via Western blotting and direct and indirect stain flow cytometry ( Figure 4B ).
CD44 expression and HA binding showed a positive correlation (both M1 > M0 ≥ M2), more clearly for HA in a soluble form than when on the nanoparticles surface. In literature the higher HA binding for TNF-α (M1) than for IL-4 (M2)-treated macrophages has been ascribed only to differences in CD44 post-translational modification, [53] but our data show also a link to its actual level of expression.
Surprisingly, we have recorded a negative correlation between HA internalization and CD44 expression for all the three HA systems studied, i.e., the amount of internalized HA material appeared to reduce with increasing levels of CD44. This unexpected phenomenon could be due to HA internalization being mediated by receptors other than CD44; the transfer of HA to these putative internalization receptors would require its decomplexation from CD44, which is likely to be slowed down by a larger CD44 expression. A different level of clustering with different CD44 expression can also be invoked. Indeed confocal microscopy showed that the co-localization between internalized HA and CD44 was rather limited (Figure 4C ), and it appeared to be higher for M1, which showed both the highest CD44 expression and the slowest internalization.
Conclusion
In this study, we have validated a robust polarization method for THP-1 cells, and used them as an in vitro model to study the role of human macrophage polarization in the CD44-mediated uptake of HA-based systems. We have shown that the expression of CD44 is polarization-dependent: not only CD44v6 (normally associated with tumors) was found exclusively in M2 macrophages, but also the overall CD44 amount scaled as M1 > M0 ≥ M2. Intriguingly, the same order was found in the capacity of macrophages to bind soluble HA and two kinds of HA-displaying nanoparticles, but their internalization appeared to follow an inverse order. This may profoundly affect the efficiency of a delivery approach: paradoxically, cells with the highest CD44 expression and potentially the best 'binders' may turn out to be the most difficult to, e.g., transfect with a nucleic acid payload, because of the slower/more difficult internalization of the HA carrier structure. . A) Uptake of HA-Rho (left) and of CS/HA nanoparticles (center and right) followed by flow cytometry (purple) and fluorimetry of cell lysates (black; the lysate data are normalized against the protein content). Please note that the flow cytometry data of CS/HA nanoparticles are obtained by monitoring the fluorescence of the nanoparticle cargo i.e. DY547-labeled siRNA (purple). B) Cross-correlation between the expression of CD44 (CD44pan; measured through Western blotting and both direct and indirect stain. flow cytometry) and HA or CS/HA binding (cell lysate at 2 h, top) and internalization (flow cytometry at 16 h, bottom). Please note that the CD44 expression is normalized against M0 independently for each analytical technique. C) Confocal microscopy acquisitions of fixed THP-1 macrophages after incubation with HA-Rho for 16 h and counter-staining with anti-CD44pan mAb. Scale bars: 10 µm. D) Effect of CD44 antibody treatment on the uptake of HA-Rho. THP-1 macrophages were pre-treated with 20 µg mL −1 Hermes-I antibody followed by a 2 h incubation with medium containing both 10 µg mL −1 antibody and 125 µg mL −1 HA-Rho (n = 3). Statistical analysis: M1, ** P = 0.0005; M2, *P = 0.00039 (Two-way ANOVA). The only partial inhibition is not a concern: a max 50% inhibition is common for Hermes-1, which is nevertheless one of the best means to reduce HA internalization in human cells. [51] Please note that only few anti-CD44 antibodies bind close enough to the LINK module to reduce HA uptake. [52] followed by addition of 2 g of NaHCO 3 (ReagentPlus ≥99.5%, powder, S8875, Sigma-Aldrich, UK). The pH was then adjusted to 7.1 by adding 1 m HCl and the volume brought to 390 mL with distilled water. The resulting medium was filtered using Disposable Sterile Filter Systems 0.22 µm (Corning, UK) and supplemented accordingly (20% (v/v) FBS and 2% (v/v) antibiotic-antimycotic solution, referred to a final volume of 500 mL.
Experimental Section
Differentiation Protocols: PMA concentration-PMA (P1585, Sigma-Aldrich, UK) was used at different concentrations, as high as 200 ng mL −1 (18 h) [54] or 200 × 10 −9 m (≈120 ng mL −1 , 24 h), [28] or as low as 25 × 10 −9 m (≈15 ng mL −1 , 48 h) [55] or 5 ng mL −1 (48 h); [33] the authors chose an intermediate concentration (50 ng mL −1 ) to avoid undesired gene upregulation seen with larger doses, [33] but still provide a stable attachment of differentiated cells over the 24 h period.
Cell Density: It has been observed that more homogeneous THP-1 populations can be obtained using relatively low (<1 × 10 6 cells mL −1 ) premonocyte cell density; [35] in this study the authors have employed 5 × 10 5 cells mL −1 , corresponding to 1.25 × 10 5 cells cm −2 in case of full attachment. All the cytokines mentioned below were purchased from Prepotech, Inc.
A) For premonocyte-M0 differentiation, the cells were incubated for 24 h with 50 ng mL −1 PMA in complete medium. Differentiated, adherent cells were washed twice with serum-free medium and then rested for a further 24 or 48 h in PMA-free complete medium to obtain resting macrophages respectively defined as M0 [24] or M0
[24]* . B) For premonocyte-M1 differentiation/polarization, in complete medium, the cells were treated either for 6 h with 50 ng mL −1 PMA, and then coincubated with 100 ng mL −1 LPS from Escherichia coli O26:B6 (L8274, Lot. #032M4089V, Sigma-Aldrich, UK), 20 ng mL −1 IFN-γ (#300-02, Lot #081427) and 50 ng mL −1 PMA for the following 18 h (followed by a 24 h resting phase complete medium), or for 24 h with 50 ng mL −1 PMA, and with 100 ng mL −1 LPS and 20 ng mL The MFI of the isotype control (Mouse IgG1; AbD Serotec, UK) was used as threshold to calculate the MFI of the marker of interest. Shifts in the FSC and SSC signal along macrophage differentiation and polarization were also analyzed to evaluate phenotypical changes (cell size and inner cellular complexity). The same detachment procedure (without staining) was used to assess size and granularity for the morphological analysis.
B) Indirect Staining: THP-1 premonocytes were differentiated to M0, [48] M1, [24/24] and M2 [24/24] in Costar polystyrene 6-well plates (3506, Corning, UK). Cells were detached using pre-warmed Cell Dissociation Buffer, Enzyme-Free, PBS (#13151-014, Gibco/Invitrogen, UK). Approximately 0.5 × 10 6 cells were suspended in 100 µL FACS buffer per sample tube (1. Western Blot Analysis: THP-1 premonocytes were differentiated and polarized in Costar 25 cm 2 polystyrene angled neck flasks (3056, Corning, UK). Total cell extracts were prepared in ice-cold RIPA Buffer (R0278, Sigma-Aldrich, UK) supplemented with CompleteUltra Tablets, Mini, EDTA-free EASYpack (#05892791001, Roche, Germany) and stored at −80 °C until use. Equal amounts of protein (cell lysates) in Laemmli buffer containing 5% (v/v) 2-mercaptoethanol (M3148, Sigma-Aldrich, UK) were separated by 7.5% acrylamide SDS-PAGE using a Criterion Cell (#165-6001; Run settings: 1 hr, 100 V, 0.5 A) and transferred to a PVDF membrane (polyvinylidene fluoride, #162-0177) using a Criterion Blotter (#170-4070; Run settings: 30 min, 100 V, 0.5 A). Membranes were blocked by incubation with 5% (w/v) non-fat milk (#70166, Lot. #BCB68664V, Fluka, UK) in TBS-T (0.1% Tween-20 SigmaUltra-P7949, Sigma-Aldrich, UK-in 1× Tris-buffer -#170-6435) for 1 h at room temperature. Membranes were then cut into two sections and incubated with 1:1000 dilution in TBS-T mouse anti-human CD44 (Clone 156-3C11, #170-5061; Cell Signaling Technology, UK) overnight at 4 °C, or 1:5000 dilution in TBS-T rabbit anti-human β-actin (ab8227, Abcam, UK) for 1 h at room temperature. After four washings in TBS-T (15 min per wash under gentle agitation), membranes were incubated for 1 h at room temperature with goat anti-mouse IgG-peroxidase (A0168, SigmaAldrich, UK) or goat anti-rabbit IgG-peroxidase (A0545, SigmaAldrich, UK), respectively. Bands were detected using Clarity Western enhanced chemiluminescence substrate (#170-5061) with the aid of a ChemiDoc MP System (#170-8280). ImageJ software (v1.49p, http://rsb. info.nih.gov/ij) was used to perform a densitometry analysis of protein bands. Unless specified, all the products herein mention were purchased from Bio-Rad, UK.
Cytokine Profiling: The Ready-SET-Go! ELISA kits for Human TNF-α (#88-7346-88), Human IL-1β Second Generation, #88-7261-88), Human IL-10 (#88-7106-88), Human TGF-β1 (Second Generation, #88-8350-88), and Corning Costar flat-bottom ELISA plates used in this study were all purchased from Affymetrix/eBioscience (UK) and used according to manufacturer's protocols.
Cell Imaging:
A) Light Microscopy: Phase contrast images of live THP-1 macrophages were acquired using a Leica DMI6000B inverted microscope (Leica Microsystems, UK) coupled with a 5. was used to acquire volumetric datasets of resting and polarized THP-1 macrophages. Confocal acquisitions were performed using the immersion oil 63×/1.40 HCX PL Apo objective.
THP-1 Morphology and CD44
Staining: THP-1 macrophages were stained for F-actin and nuclei after each differentiation procedure. Briefly, cells were incubated for 10 min with 1 µg mL −1 Hoechst (Invitrogen, Thermo-Fisher, UK) solution in serum-free medium at 37 °C and 5% (v/v) CO 2 , cells were washed with PBS, fixed with 4% paraformaldehyde (PFA) solution for 10 min at room temperature, washed again with PBS, and then permeabilized with 0.1% (v/v) TritonX-100 solution in PBS (3 min incubation at room temperature). Cells were finally incubated for 20 min at room temperature with 1:200 Phalloidin-AlexaFluor488 (Invitrogen, Thermo-Fisher, UK) in 1% (w/v) bovine serum albumine (BSA) PBS solution, then washed with PBS, and stored in the dark at 4 °C in a 1 mg mL −1 ascorbic acid/PBS solution. Images of polarized THP-1 macrophages were acquired using an inverted confocal laser microscope (Leica SP5). ] protocols were analyzed using ImageJ (v1.49p, http://rsb.info.nih.gov/ij). The morphological analysis was performed considering the F-actin channel on volumetric datasets (n = 2) analyzing about ten cells per phenotype/method. Cell thickness was measured considering the difference between basal and the apical z-level. The measured difference was then multiplied by the z-size of the dataset voxel, obtaining the average thickness of each acquired cell. Cell surface area and solidity were measured using dataset maximum projections, Otsu threshold and watershed method were applied respectively to select cell bodies and to separate cell projections. Finally the surface area and the shape descriptors were determined using ImageJ plug-ins. In this study, the authors present only solidity as the most representative descriptor to distinguish the macrophages phenotype/method. HA Internalization: Sections and high-resolution (3D-HR) volumetric dataset were also acquired to precisely determine HA-Rho localization within the cell. For 3D-HR acquisitions, the confocal settings were set as follows: 1 Airy unit, scan speed 700 Hz, Average Line ×2, pixel size 117 nm, 0.4 µm z-step. To get rid of any possible cross talk between channels, images were collected with a sequential scan, using the following laser lines and mirror settings: 405(10%)/410-460 nm; 488(30%)/500-550 nm; 561(25%)/575-680 nm. Sections were then processed and analyzed using ImageJ, accordingly to the acquisition analysis. 3D rendering was performed using Imaris x64 (v7.7.2, Bitplane AG). Before acquisitions, the bottom and the top level were determined using the F-actin signal. At a post-processing level, the following morphological parameters were calculated: -Approximated cell thickness, determined as the average basal versus apical plane distance for each cell.
-Average surface area, determined with the maximum projection result of the volumetric dataset.
-Solidity of cell surface, determined after applying threshold method and calculating shape descriptors of the maximum projection (derived from volumetric dataset).
Preparation of Fluorescently-Labeled HA (HA-Rho):
Hyaluronic acid (M w = 180 kDa, assessed by gel permeation chromatography (GPC) as described in Section SI5 and Table 1SI in the Supporting Information) was provided by Novozymes (Bagsvaerd, Denmark) and covalently conjugated to Lissamine Rhodamine B Ethylenediamine (Thermo Scientific, UK). All solutions were prepared in 100 × 10 −3 m HEPES buffer at pH = 7.4 unless stated otherwise. Briefly, 150 mg of HA (0.5 mmol of carboxylate) were dissolved in 15 mL by shaking overnight. After complete dissolution of HA, 3.75 mL of a solution containing 4.32 mg of Rhodamine were added followed by 3.75 mL of a 65 × 10 −3 m 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride solution (Sigma-Aldrich, UK). The reaction was stirred (at 300 rpm) for 24 h at 25 °C and then quenched and precipitated using a 20-fold volume excess of ethanol (96%, v/v). The mixture was further incubated overnight at 4 °C to ensure the complete precipitation of the labeled HA. The precipitate was collected after centrifugation (10 min at 4500 g), dissolved in 15 mL of deionized water, and purified by dialysis (MW cut-off 20 kDa). Finally, the HA solution was freeze-dried. Mass recovery: 74%. Degree of derivatization: 0.7% mol (calculated by measuring the fluorescence of Rhodamine-conjugated HA (Ex: 540/25, Em: 620/40 nm) and comparing it to a calibration with free Rhodamine).
Preparation of HA-Coated Chitosan Nanoparticles (CS/HA): Chemicals. Middle viscosity chitosan (average viscosimetric molecular weight M v = 656 kDa) and degree of deacetylation 85%) was purchased from Sigma (Sigma-Aldrich, UK). Chitosan with M v = 36 kDa was obtained by oxidative degradation of middle viscosity chitosan (1 wt% in 0.1 m HCl/3 × 10 −3 m sodium nitrite). Chitosan samples were purified in-house prior to use as previously described. [56] Nanoparticle Preparation: Nanoparticles were prepared by direct complexation of chitosan with HA and siRNA, following a single-step method recently adopted in the group; please note that this is not the two-stage triphosphate-mediated process previously employed by the authors. [21, 56] This simplified approach encompassed first the preparation of a 0.069 wt% CS solution (36 or 656 kDa) in 4.6 × 10 −3 m HCl, the pH of the solution was then adjusted to 5 by adding 0.1 × 10 −3 m NaOH. The latter was further diluted 1:2 (v/v) with deionized water brought to pH = 5 using HCl 0.1 m; in the case of loaded nanoparticles, the CS solution was diluted with deionized nuclease-free water containing DY547-labeled siRNA (1.45 wt% in relation to CS) (Dharmacon, UK) and an initial complexation was carried under magnetic agitation (1000 rpm) for 10 min at 25 °C. The HA-coated nanoparticles (CS/ HA) were obtained by addition of the resulting CS solution/suspension into an equal volume of a 1.5 mg mL −1 HA solution (HA-Rho for empty nanoparticles; non-labeled HA for the siRNA-loaded ones) in water at pH = 5 under vigorous stirring (1000 rpm) for 30 min at 25 °C. Please note that the preparation of nanoparticles was performed in a laminar flow hood with surfaces previously decontaminated using the RNaseZap solution (Thermo Scientific, UK) when encapsulating siRNA payloads. Size and ζ-potential of the particles are reported in Section SI5 and Table 1SI in the Supporting Information.
Study of Macrophage-HA Interactions: In the following paragraphs, the authors will refer to soluble HA or CS/HA nanoparticles as "treatment." Briefly, equal volumes of soluble HA or CS/HA nanoparticles (adjusted to 250 µg mL −1 with deionized water) were diluted with 2× concentrated RPMI 1640 medium to obtain a final concentration of 125 µg mL −1 in complete cell culture medium.
Please note that internalization studies (flow cytometry) of soluble HA were performed by tracking the HA-Rho signal, while those of CS/HA nanoparticles were performed by tracking an encapsulated fluorescentlylabelled siRNA, respectively (see previous section for the preparation procedure). Statistical Analysis: The expression of markers and cytokines was compared using a two-way analysis of variance (Two-way ANOVA), setting the macrophage phenotype (i.e., M0, M1, or M2) as row factor and the differentiation/polarization method as column factor. In experiments related to CD44 isoforms and CD44-mediated uptake inhibition, the authors compared results between different phenotypes using one-way analysis of variance (One-way ANOVA). Differences between groups were considered significant at a P value of <0.05. Statistical analysis performed with GraphPad Prism 6.04 (GraphPad Software, Inc., San Diego, CA).
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Supporting Information is available from the Wiley Online Library or from the author.
